Office of inspections and investigations? (OII), office of training, education, and development (oted), technical and learning management system (LMS) support
Ended Awarded
- Contract number
- 75F40125F19010
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $85,421
Award facts
- Contract value 100% obligated
- $85,420.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Labor Hours
- Place of performance
- Ivins, UT, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business. The contract is for $85,420.80 and provides professional, administrative, and consulting services in support of the FDA's Office of Inspections and Investigations (OII) and Office of Training, Education, and Development (OTED).
The contract is part of the FDA's larger Professional, Administrative, and Consulting Services (PACS) Indefinite Delivery Contract (IDC), a $100 million single-award vehicle set aside for competitive 8(a) businesses. Kaiva Strategies also holds a separate $22 million IDC with the FDA for medical writing support services. Under these IDCs, the FDA has issued numerous task orders for Kaiva to provide a range of professional services, including writer/editor support, medical writing, scientific communication, and administrative support across different centers and offices within the agency.
The contract has a period of performance through July 2026 and does not utilize a set-aside designation.
Quick answers
Who was awarded contract 75F40125F19010?
75F40125F19010 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on August 12, 2025.
How much is contract 75F40125F19010 worth?
The government has obligated $85,421 on 75F40125F19010.
Is contract 75F40125F19010 an order under another contract?
Yes. 75F40125F19010 is a delivery order under 75F40123D00021, an indefinite delivery contract.
Was contract 75F40125F19010 competed?
The extent of competition for 75F40125F19010 was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award